Eksigent Technologies (Dublin, California) reported relocation of its headquarters to the Creekside Business Park in Dublin. The new 43,000-square-foot facility doubles the company’s original space and will accommodate R&D, operations, manufacturing and shipping, plus sales and marketing and customer service.
It includes a customer demonstration center and research labs for the company’s HPLC, medical device and technology development.
Jeff Jensen, company president, said, “Our company has experienced rapid growth over the past few years, with the successful introductions of our HPLC and drug-delivery product lines.”
Eksigent develops microfluidic systems that automate and accelerate proteomics, drug discovery, medical devices and other life science applications. The company offers solutions for nanoscale liquid chromatography, high-performance liquid chromatography and microscale pumps.